A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research319 enrolled

Overview

The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

319

Conditions

Glaucoma Ocular Hypertension

Interventions

Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)DRUG

One drop in the study eye(s) once daily, 9 PM, for 6 weeks

Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)DRUG

One drop in the study eye(s) twice daily for 6 weeks

Timolol VehicleOTHER

One drop in the study eye(s) once daily for 6 weeks

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 or older. * Diagnosis of glaucoma or ocular hypertension. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Under 18. * Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Mean Intra-Ocular Pressure (IOP)

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.